X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA STERLING BIOTECH ELDER PHARMA/
STERLING BIOTECH
 
P/E (TTM) x -0.2 -0.4 - View Chart
P/BV x 0.1 0.0 708.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   STERLING BIOTECH
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
STERLING BIOTECH
Dec-13
ELDER PHARMA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs38011 3,619.0%   
Low Rs1883 5,529.4%   
Sales per share (Unadj.) Rs491.226.8 1,832.3%  
Earnings per share (Unadj.) Rs-3.2-15.0 21.3%  
Cash flow per share (Unadj.) Rs14.4-5.5 -263.8%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.554.9 686.0%  
Shares outstanding (eoy) m20.54267.87 7.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.3 223.0%   
Avg P/E ratio x-89.3-0.5 19,210.1%  
P/CF ratio (eoy) x19.7-1.3 -1,549.3%  
Price / Book Value ratio x0.80.1 595.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8331,862 313.3%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m2,179547 398.5%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m10,0897,181 140.5%  
Other income Rs m25743 602.3%   
Total revenues Rs m10,3467,223 143.2%   
Gross profit Rs m-792947 -83.6%  
Depreciation Rs m3612,543 14.2%   
Interest Rs m2,7564,377 63.0%   
Profit before tax Rs m-3,653-5,931 61.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-1,924 -6.5%   
Profit after tax Rs m-65-4,007 1.6%  
Gross profit margin %-7.813.2 -59.5%  
Effective tax rate %-3.432.4 -10.6%   
Net profit margin %-0.6-55.8 1.2%  
BALANCE SHEET DATA
Current assets Rs m9,24014,335 64.5%   
Current liabilities Rs m9,99849,809 20.1%   
Net working cap to sales %-7.5-494.0 1.5%  
Current ratio x0.90.3 321.1%  
Inventory Days Days46403 11.5%  
Debtors Days Days60171 35.1%  
Net fixed assets Rs m10,12455,432 18.3%   
Share capital Rs m206268 76.8%   
"Free" reserves Rs m5,58213,935 40.1%   
Net worth Rs m7,73414,701 52.6%   
Long term debt Rs m4,8899,478 51.6%   
Total assets Rs m22,88273,988 30.9%  
Interest coverage x-0.3-0.4 91.6%   
Debt to equity ratio x0.60.6 98.1%  
Sales to assets ratio x0.40.1 454.3%   
Return on assets %11.80.5 2,347.8%  
Return on equity %-0.8-27.3 3.1%  
Return on capital %22.3-6.4 -347.2%  
Exports to sales %3.025.9 11.7%   
Imports to sales %0.40.2 251.4%   
Exports (fob) Rs m3071,860 16.5%   
Imports (cif) Rs m4312 353.3%   
Fx inflow Rs m3071,860 16.5%   
Fx outflow Rs m12525 503.4%   
Net fx Rs m1811,835 9.9%   
CASH FLOW
From Operations Rs m11,7541,719 683.9%  
From Investments Rs m-561-3,148 17.8%  
From Financial Activity Rs m-6,7621,426 -474.2%  
Net Cashflow Rs m4,432-3 -130,344.1%  

Share Holding

Indian Promoters % 39.6 33.9 116.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 16.8 9.9 169.7%  
ADR/GDR % 0.0 16.9 -  
Free float % 36.1 39.3 91.9%  
Shareholders   16,479 21,482 76.7%  
Pledged promoter(s) holding % 77.6 55.9 138.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   WYETH LTD  PFIZER  NATCO PHARMA  SUN PHARMA  SANOFI INDIA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - WYETH LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS